|
Volumn 16, Issue 11, 2010, Pages 1332-1333
|
Feasibility of ABO-incompatible living donor liver transplantation in the rituximab era
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCINEURIN INHIBITOR;
IMMUNOGLOBULIN;
RITUXIMAB;
BLOOD GROUP ABO INCOMPATIBILITY;
CLINICAL TRIAL;
CYTOMEGALOVIRUS INFECTION;
DRUG SAFETY;
FEASIBILITY STUDY;
GRAFT VERSUS HOST REACTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
JAPAN;
KIDNEY TRANSPLANTATION;
LETTER;
LIVER FAILURE;
LIVER GRAFT;
LIVER TRANSPLANTATION;
LIVING DONOR;
PRIORITY JOURNAL;
SURVIVAL RATE;
SURVIVAL TIME;
ABO BLOOD-GROUP SYSTEM;
ADULT;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
B-LYMPHOCYTES;
BLOOD GROUP INCOMPATIBILITY;
CALCINEURIN;
HUMANS;
IMMUNITY, HUMORAL;
INJECTIONS, INTRAVENOUS;
LIVER;
LIVER FAILURE, ACUTE;
LIVER TRANSPLANTATION;
LIVING DONORS;
PERIODICITY;
PLASMA EXCHANGE;
TRANSPLANTATION;
TREATMENT OUTCOME;
|
EID: 78349248316
PISSN: 15276465
EISSN: 15276473
Source Type: Journal
DOI: 10.1002/lt.22160 Document Type: Letter |
Times cited : (9)
|
References (6)
|